Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects
- PMID: 9400003
Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects
Abstract
The ability of the delta opioid agonist DPDPE ([D-Pen2, D-Pen4]enkephalin) to stimulate binding of the GTP analog guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) to pertussis toxin-sensitive G proteins has been characterized in membranes from NG108-15 mouse neuroblastoma X rat glioma cells. The presence of GDP, or its hydrolysis-resistant analog GDPbetaS, and Mg++ ions was essential to observe agonist-mediated stimulation of [35S]GTPgammaS binding, although the guanine dinucleotides alone had complex inhibitory and stimulatory effects on [35S]GTPgammaS binding. The relative ability of the delta antagonists benzylidenenaltrexone and naltriben to inhibit DPDPE-stimulated [35S]GTPgammaS binding suggested the opioid receptor involved was of the delta-2 subtype. Ligand binding assays demonstrated biphasic binding of these antagonists to this single receptor type. [35S]GTPgammaS binding was also stimulated by [D-Ser2,Leu5,Thr6]enkephalin > deltorphin II = DPDPE = etorphine > levallorphan = diprenorphine = nalorphine = naltrindole. The delta antagonists benzylidenenaltrexone, TIPP (Tyr-Tic-Phe-Phe) and naltriben had no effect, but ICI 174864 (N, N-diallyl-Tyr-Aib-Phe-Leu-OH) acted as an inverse agonist and inhibited [35S]GTPgammaS binding. Pertussis toxin pretreatment blocked agonist stimulation of [35S]GTPgammaS binding and also reduced basal binding, thus confirming the presence of constitutively active delta receptors. Replacement of Na+ in the assay buffer with K+ afforded an increased level of basal [35S]GTPgammaS binding and an apparent increase in both the inverse agonist activity of ICI 174864 and the agonist activity of the partial agonist diprenorphine relative to the full agonist [D-Ser2, Leu5,Thr6]enkephalin. The stimulation of [35S]GTPgammaS binding to NG108-15 cell membranes allows a functional measure of delta opioid activity that can provide systems of differing relative efficacy.
Similar articles
-
Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor.J Pharmacol Exp Ther. 1997 Nov;283(2):501-10. J Pharmacol Exp Ther. 1997. PMID: 9353363
-
Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.Mol Pharmacol. 1995 Apr;47(4):848-54. Mol Pharmacol. 1995. PMID: 7723747
-
Chronic agonist treatment converts antagonists into inverse agonists at delta-opioid receptors.J Pharmacol Exp Ther. 2002 Sep;302(3):1070-9. doi: 10.1124/jpet.102.035964. J Pharmacol Exp Ther. 2002. PMID: 12183665
-
[Effects of newly isolated opioid peptides on G-protein activation: usefulness of [35S] GTP gamma S binding study and its practical application].Nihon Shinkei Seishin Yakurigaku Zasshi. 1998 Aug;18(4):107-16. Nihon Shinkei Seishin Yakurigaku Zasshi. 1998. PMID: 9866825 Review. Japanese.
-
An overview on functional receptor autoradiography using [35S]GTPgammaS.Brain Res Brain Res Rev. 2001 Dec;38(1-2):149-64. doi: 10.1016/s0165-0173(01)00106-0. Brain Res Brain Res Rev. 2001. PMID: 11750931 Review.
Cited by
-
Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.Br J Pharmacol. 2002 Jan;135(2):383-92. doi: 10.1038/sj.bjp.0704490. Br J Pharmacol. 2002. PMID: 11815373 Free PMC article.
-
Neutral antagonist activity of naltrexone and 6beta-naltrexol in naïve and opioid-dependent C6 cells expressing a mu-opioid receptor.Br J Pharmacol. 2009 Apr;156(7):1044-53. doi: 10.1111/j.1476-5381.2008.00035.x. Epub 2009 Feb 13. Br J Pharmacol. 2009. PMID: 19220294 Free PMC article.
-
The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.Psychopharmacology (Berl). 2015 Jan;232(1):305-14. doi: 10.1007/s00213-014-3666-3. Epub 2014 Jun 29. Psychopharmacology (Berl). 2015. PMID: 24973897 Free PMC article.
-
Novel cyclic biphalin analogue with improved antinociceptive properties.ACS Med Chem Lett. 2014 Jul 14;5(9):1032-6. doi: 10.1021/ml500241n. eCollection 2014 Sep 11. ACS Med Chem Lett. 2014. PMID: 25221662 Free PMC article.
-
Determining pharmacological selectivity of the kappa opioid receptor antagonist LY2456302 using pupillometry as a translational biomarker in rat and human.Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu036. doi: 10.1093/ijnp/pyu036. Int J Neuropsychopharmacol. 2014. PMID: 25637376 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Molecular Biology Databases